IRIS
PATRONE, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.318
AS - Asia 2.335
NA - Nord America 1.771
SA - Sud America 192
AF - Africa 39
OC - Oceania 8
Totale 28.663
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 23.939
US - Stati Uniti d'America 1.654
SG - Singapore 992
CN - Cina 586
VN - Vietnam 406
FR - Francia 183
BD - Bangladesh 136
BR - Brasile 106
HK - Hong Kong 71
DE - Germania 51
CA - Canada 48
AR - Argentina 43
JP - Giappone 29
CH - Svizzera 28
IN - India 28
FI - Finlandia 27
MX - Messico 26
GB - Regno Unito 24
EC - Ecuador 19
IQ - Iraq 15
ZA - Sudafrica 14
ID - Indonesia 13
NL - Olanda 12
PH - Filippine 12
RU - Federazione Russa 11
ES - Italia 9
JM - Giamaica 9
CR - Costa Rica 8
MA - Marocco 8
UZ - Uzbekistan 8
AU - Australia 7
CO - Colombia 7
HN - Honduras 7
IE - Irlanda 6
TH - Thailandia 6
UA - Ucraina 6
CL - Cile 5
KR - Corea 5
TR - Turchia 5
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
PK - Pakistan 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AZ - Azerbaigian 3
GT - Guatemala 3
PA - Panama 3
PL - Polonia 3
SV - El Salvador 3
UY - Uruguay 3
BB - Barbados 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
SE - Svezia 2
AL - Albania 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
NG - Nigeria 1
PF - Polinesia Francese 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
YT - Mayotte 1
Totale 28.663
Salva come PNG Salva come JPEG
Città #
Genova 15.082
Genoa 5.090
Rapallo 2.204
Vado Ligure 1.289
San Jose 477
Singapore 445
Lauterbourg 174
Ashburn 147
Ho Chi Minh City 134
New York 94
Hanoi 83
Beijing 78
Milan 71
Hong Kong 68
Santa Clara 51
Frankfurt am Main 44
Bordighera 42
Los Angeles 34
Zurich 28
Helsinki 27
Valenza 27
Tokyo 25
Dallas 24
Chicago 20
Da Nang 16
Council Bluffs 15
Haiphong 14
Mexico City 14
Phoenix 14
Tianjin 14
Buffalo 13
Naples 13
Orem 13
Biên Hòa 12
Rome 12
Montreal 11
Washington 11
Atlanta 10
Newark 10
Amsterdam 9
Cardiff 9
Columbus 9
Delhi 9
São Paulo 9
Des Moines 8
Jacksonville 8
Johannesburg 8
Rovereto 8
Charlotte 7
Hải Dương 7
Ninh Bình 7
Philadelphia 7
San Francisco 7
Baghdad 6
Brooklyn 6
City of London 6
Houston 6
Las Vegas 6
Lawrenceville 6
London 6
San José 6
The Bronx 6
Thái Bình 6
Turin 6
Buenos Aires 5
Can Tho 5
Dublin 5
Memphis 5
Mumbai 5
Nha Trang 5
Quito 5
Rio de Janeiro 5
San Bernardino 5
San Pedro Sula 5
Seattle 5
Tashkent 5
Toronto 5
Birmingham 4
Bình Phước 4
Cape Town 4
Denver 4
Florence 4
Kingston 4
Nairobi 4
Nashville 4
Paris 4
Queens 4
Quezon City 4
Quảng Ngãi 4
Secaucus 4
Shanghai 4
Sydney 4
Warsaw 4
Wenzhou 4
Agadir 3
Austin 3
Baku 3
Bari 3
Bogotá 3
Cagliari 3
Totale 26.279
Salva come PNG Salva come JPEG
Nome #
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 326
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 279
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 262
APO866 activity in hematologic malignancies: a preclinical in vitro study. 252
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 252
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 248
Autophagy in blood cancers: biological role and therapeutic implications. 241
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 233
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 226
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 218
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 212
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 210
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 208
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 206
Ras-induced resistance to lapatinib is overcome by MEK inhibition 205
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 203
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 201
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 200
Anticancer vaccination strategies. 200
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 199
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 199
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 196
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 195
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 195
Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives. 193
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 192
Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. 192
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 192
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 191
In vitro function of chronic myelocytic leukemia granulocytes. Effects of irradiation and storage. 191
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 191
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 190
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. I. Specimens mounted in neutral resin]. 186
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 185
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 185
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 183
A monoclonal antibody to platelet glycoproteins IIb and IIIa complex: its use in purifying human megakaryocytes from sternal bone marrow aspirates for immunofluorescence studies of Ia-like antigens. 183
Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors 183
A simple acid-precipitation test for rapid screening of monoclonal gammopathies. 182
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 181
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 181
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 180
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 180
Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis 179
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 179
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 179
[Degradation of the diazo compound naphthol AS-BI phosphate-fast red violet LB salt in the evaluation of granulocyte alkaline phosphatase. II. Specimens mounted in neutral resin]. 178
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 178
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 177
High-dose cyclophosphamide followed by gm-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells 176
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 173
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 173
Identification of mouse bone marrow colony growth in agar-cultures by the nitroblue tetrazolium dye. 171
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 170
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 170
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells 168
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 167
Dose-dense vinorelbine and paclitaxel with granulocyte colony-stimulating factor in metastatic breast cancer patients: anti-tumor activity and peripheral blood progenitor cell mobilization capability 164
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 164
Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. 163
The use of dendritic cells in cancer immunotherapy. 162
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer 161
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis 159
In vitro effects of synthetic chemotactic peptides on neutrophil function. 158
[Cytochemical semiquantitative evaluation of peroxidase activity in blood cells. Method]. 158
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 158
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 157
Targeting NAD(+) Salvage Pathway Induces Autophagy in Multiple Myeloma Cells 155
HDAC INHIBITORS SYNERGISTICALLY ENHANCE AP0866 ACTIVITY IN HUMAN LEUKEMIA CELLS: EVIDENCE FOR CONVERGING MECHANISMS OF SIRT1 INHIBITION 154
New insights into biology of chronic myeloid leukemia: implications in therapy. 154
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. 154
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib 153
Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. 151
Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity. 151
Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 151
Autologous peripheral blood stem cells (PBSC) in breast cancer. 150
Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with early breast cancer with four or more positive lymph nodes. 150
Targeting NAD+ Salvage Pathway Induces Autophagy in Multiple Myeloma Cells via mTORC1 and Extracellular Signal-Regulated Kinase (ERK1/2) Inhibition 149
Neutrophil chemotaxis: physiology and pathology. 149
Platelets as scavengers of neutrophil-derived oxidants: a possible defence mechanism at sites of vascular injury. 149
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor cell rescue for metastatic breast cancer 147
Standard-dose recombinant human granulocyte colony-stimulating factor (rhG-CSF) allows safe and repeated administration of high-dose cyclophosphamide, etoposide and cisplatin (CEP) 146
Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. 146
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial. 146
Hyperimmunoglobulinemia E syndrome. 145
New insights into the treatment of multiple myeloma with histone deacetylase inhibitors. 145
Monocyte-derived macrophages as helper cells in monocyte-mediated cytolysis. 144
Duplication of the der(13)t(12;13)(p13;q14) in chronic myelomonocytic leukemia. 144
Enhancement of the in vitro colony-forming capacity of human T lymphocytes induced by levamisole. 144
[Semiquantitative evaluation of leukocyte acid phosphatase]. 144
Neutrophil functions in acne conglobata. 142
Proteasome inhibitors: antitumor effects and beyond 141
NAD plus -dependent histone deacetylase SIRT6 regulates immune cell function and omeostasis 141
The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. 141
Effector-target co-aggregation as a crucial step in the neutrophil-mediated tumour cell lysis. 140
[Distribution of acid phosphatase activity in white blood cells]. 139
Stimulation of neutrophil locomotion by inosiplex. 139
High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer 138
Defective neutrophil mobilization to skin chambers in cancer patients. 138
Stimulation of granulocyte adhesiveness by the chemotactic peptide N-formyl-L-methionyl-L-phenylalanine. 137
Totale 17.766
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.998
article - articoli 80.252
book - libri 0
conference - conferenze 510
curatela - curatele 0
other - altro 0
patent - brevetti 176
selected - selezionate 0
volume - volumi 1.060
Totale 163.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.402 57 182 172 256 176 144 128 536 78 243 109 321
2022/20232.651 270 195 18 290 437 490 12 199 462 12 241 25
2023/20241.256 44 159 23 148 99 268 43 140 54 21 64 193
2024/20253.235 109 270 95 213 454 272 296 592 87 135 306 406
2025/20265.919 731 150 281 520 786 581 1.030 244 379 610 318 289
2026/2027521 521 0 0 0 0 0 0 0 0 0 0 0
Totale 28.763